Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer

MLA

Xiaoyi Yan, et al. “Development and Validation of a Nomogram Model Based on Pretreatment Ultrasound and Contrast-Enhanced Ultrasound to Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer.” Cancer Imaging, vol. 24, no. 1, Jan. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40644-024-00662-2.

APA

Xiaoyi Yan, Xianshui Fu, Yang Gui, Xueqi Chen, Yuejuan Cheng, Menghua Dai, Weibin Wang, Mengsu Xiao, Li Tan, Jing Zhang, Yuming Shao, Huanyu Wang, Xiaoyan Chang, & Ke Lv. (2024). Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer. Cancer Imaging, 24(1), 1–12. https://doi.org/10.1186/s40644-024-00662-2

Chicago

Xiaoyi Yan, Xianshui Fu, Yang Gui, Xueqi Chen, Yuejuan Cheng, Menghua Dai, Weibin Wang, et al. 2024. “Development and Validation of a Nomogram Model Based on Pretreatment Ultrasound and Contrast-Enhanced Ultrasound to Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer.” Cancer Imaging 24 (1): 1–12. doi:10.1186/s40644-024-00662-2.